These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39111563)

  • 1. Pharmaceutical-mediated neuroimmune modulation in psychiatric/psychological adverse events.
    Marques SI; Sá SI; Carmo H; Carvalho F; Silva JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Dec; 135():111114. PubMed ID: 39111563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury.
    Wu D; Liao X; Gao J; Gao Y; Li Q; Gao W
    Clin Transl Med; 2024 Aug; 14(8):e1808. PubMed ID: 39129233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis.
    Andronis C; Silva JP; Lekka E; Virvilis V; Carmo H; Bampali K; Ernst M; Hu Y; Loryan I; Richard J; Carvalho F; Savić MM
    Arch Toxicol; 2020 Aug; 94(8):2829-2845. PubMed ID: 32504122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-immune interactions in neuropsychiatric disorders: Lessons from transcriptome studies for molecular targeting.
    Afridi R; Seol S; Kang HJ; Suk K
    Biochem Pharmacol; 2021 Jun; 188():114532. PubMed ID: 33773976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multispecies approach for understanding neuroimmune mechanisms of stress.
    Deak T; Kudinova A; Lovelock DF; Gibb BE; Hennessy MB
    Dialogues Clin Neurosci; 2017 Mar; 19(1):37-53. PubMed ID: 28566946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric disorders associated with PCSK9 inhibitors: A real-world, pharmacovigilance study.
    Deng Z; Liu J; Gong H; Cai X; Xiao H; Gao W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14522. PubMed ID: 37950531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmune pharmacology of neurodegenerative and mental diseases.
    Shie FS; Chen YH; Chen CH; Ho IK
    J Neuroimmune Pharmacol; 2011 Mar; 6(1):28-40. PubMed ID: 20820930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimmune Pharmacology, 2nd Edition - A Perspective.
    Gelbard HA
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):211-212. PubMed ID: 28337573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review.
    Krsek A; Ostojic L; Zivalj D; Baticic L
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of neuroimmune interactions in human psychiatric disorders.
    Licinio J; Mastronardi C; Wong ML
    Exp Physiol; 2007 Sep; 92(5):807-11. PubMed ID: 17675415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimmune mechanisms of alcohol and drug addiction.
    Cui C; Shurtleff D; Harris RA
    Int Rev Neurobiol; 2014; 118():1-12. PubMed ID: 25175859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimmune modulation in liver pathophysiology.
    Zou J; Li J; Wang X; Tang D; Chen R
    J Neuroinflammation; 2024 Aug; 21(1):188. PubMed ID: 39090741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Putative) sex differences in neuroimmune modulation of memory.
    Tronson NC; Collette KM
    J Neurosci Res; 2017 Jan; 95(1-2):472-486. PubMed ID: 27870428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics.
    Li Z; Zhang Y; Ji M; Wu C; Zhang Y; Ji S
    Biomed Pharmacother; 2024 Jul; 176():116777. PubMed ID: 38795640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimmune Modulation of Gut Function.
    Shea-Donohue T; Urban JF
    Handb Exp Pharmacol; 2017; 239():247-267. PubMed ID: 28035531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders.
    Kokkosis AG; Tsirka SE
    J Pharmacol Exp Ther; 2020 Oct; 375(1):175-192. PubMed ID: 32661057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enduring neuroimmunological consequences of developmental experiences: From vulnerability to resilience.
    Reddaway J; Brydges NM
    Mol Cell Neurosci; 2020 Dec; 109():103567. PubMed ID: 33068720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.